scholarly journals Mathematical deep learning for pose and binding affinity prediction and ranking in D3R Grand Challenges

2018 ◽  
Vol 33 (1) ◽  
pp. 71-82 ◽  
Author(s):  
Duc Duy Nguyen ◽  
Zixuan Cang ◽  
Kedi Wu ◽  
Menglun Wang ◽  
Yin Cao ◽  
...  
Keyword(s):  
Deep Learning ◽  
Binding Affinity ◽  
Binding Affinity Prediction ◽  
Affinity Prediction ◽  
Grand Challenges

Improving the Accuracy of Protein-Ligand Binding Affinity Prediction by Deep Learning Models: Benchmark and Model

2019 ◽  
Author(s):  
Mohammad Rezaei ◽  
Yanjun Li ◽  
Xiaolin Li ◽  
Chenglong Li
Keyword(s):  
Deep Learning ◽  
Drug Design ◽  
Binding Affinity ◽  
Benchmark Dataset ◽  
Rational Drug Design ◽  
Learning Models ◽  
Structure Based Drug Design ◽  
Binding Affinity Prediction ◽  
Affinity Prediction ◽  
Rational Drug

<b>Introduction:</b> The ability to discriminate among ligands binding to the same protein target in terms of their relative binding affinity lies at the heart of structure-based drug design. Any improvement in the accuracy and reliability of binding affinity prediction methods decreases the discrepancy between experimental and computational results.<br><b>Objectives:</b> The primary objectives were to find the most relevant features affecting binding affinity prediction, least use of manual feature engineering, and improving the reliability of binding affinity prediction using efficient deep learning models by tuning the model hyperparameters.<br><b>Methods:</b> The binding site of target proteins was represented as a grid box around their bound ligand. Both binary and distance-dependent occupancies were examined for how an atom affects its neighbor voxels in this grid. A combination of different features including ANOLEA, ligand elements, and Arpeggio atom types were used to represent the input. An efficient convolutional neural network (CNN) architecture, DeepAtom, was developed, trained and tested on the PDBbind v2016 dataset. Additionally an extended benchmark dataset was compiled to train and evaluate the models.<br><b>Results: </b>The best DeepAtom model showed an improved accuracy in the binding affinity prediction on PDBbind core subset (Pearson’s R=0.83) and is better than the recent state-of-the-art models in this field. In addition when the DeepAtom model was trained on our proposed benchmark dataset, it yields higher correlation compared to the baseline which confirms the value of our model.<br><b>Conclusions:</b> The promising results for the predicted binding affinities is expected to pave the way for embedding deep learning models in virtual screening and rational drug design fields.

scholarly journals Development and evaluation of a deep learning model for protein–ligand binding affinity prediction

2018 ◽  
Vol 34 (21) ◽  
pp. 3666-3674 ◽  
Author(s):  
Marta M Stepniewska-Dziubinska ◽  
Piotr Zielenkiewicz ◽  
Pawel Siedlecki
Keyword(s):  
Deep Learning ◽  
Ligand Binding ◽  
Binding Affinity ◽  
Learning Model ◽  
Binding Affinity Prediction ◽  
Affinity Prediction ◽  
Deep Learning Model

scholarly journals Binding affinity prediction for protein–ligand complex using deep attention mechanism based on intermolecular interactions

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Sangmin Seo ◽  
Jonghwan Choi ◽  
Sanghyun Park ◽  
Jaegyoon Ahn
Keyword(s):  
Deep Learning ◽  
Binding Affinity ◽  
Prediction Models ◽  
Attention Mechanism ◽  
Scoring Functions ◽  
Ligand Complex ◽  
Structure Based Drug Design ◽  
Binding Affinity Prediction ◽  
Affinity Prediction ◽  
Proposed Model

Abstract Background Accurate prediction of protein–ligand binding affinity is important for lowering the overall cost of drug discovery in structure-based drug design. For accurate predictions, many classical scoring functions and machine learning-based methods have been developed. However, these techniques tend to have limitations, mainly resulting from a lack of sufficient energy terms to describe the complex interactions between proteins and ligands. Recent deep-learning techniques can potentially solve this problem. However, the search for more efficient and appropriate deep-learning architectures and methods to represent protein–ligand complex is ongoing. Results In this study, we proposed a deep-neural network model to improve the prediction accuracy of protein–ligand complex binding affinity. The proposed model has two important features, descriptor embeddings with information on the local structures of a protein–ligand complex and an attention mechanism to highlight important descriptors for binding affinity prediction. The proposed model performed better than existing binding affinity prediction models on most benchmark datasets. Conclusions We confirmed that an attention mechanism can capture the binding sites in a protein–ligand complex to improve prediction performance. Our code is available at https://github.com/Blue1993/BAPA.

scholarly journals Binding affinity prediction for protein-ligand complex using deep attention mechanism based on intermolecular interactions

2021 ◽  
Author(s):  
Sangmin Seo ◽  
Jonghwan Choi ◽  
Sanghyun Park ◽  
Jaegyoon Ahn
Keyword(s):  
Deep Learning ◽  
Binding Affinity ◽  
Attention Mechanism ◽  
Accurate Prediction ◽  
Scoring Functions ◽  
Ligand Complex ◽  
Binding Affinity Prediction ◽  
Affinity Prediction ◽  
Local Structures ◽  
Proposed Model

AbstractAccurate prediction of protein-ligand binding affinity is important in that it can lower the overall cost of drug discovery in structure-based drug design. For more accurate prediction, many classical scoring functions and machine learning-based methods have been developed. However, these techniques tend to have limitations, mainly resulting from a lack of sufficient interactions energy terms to describe complex interactions between proteins and ligands. Recent deep-learning techniques show strong potential to solve this problem, but the search for more efficient and appropriate deep-learning architectures and methods to represent protein-ligand complexes continues. In this study, we proposed a deep-neural network for more accurate prediction of protein-ligand complex binding affinity. The proposed model has two important features, descriptor embeddings that contains embedded information about the local structures of a protein-ligand complex and an attention mechanism for highlighting important descriptors to binding affinity prediction. The proposed model showed better performance on most benchmark datasets than existing binding affinity prediction models. Moreover, we confirmed that an attention mechanism was able to capture binding sites in a protein-ligand complex and that it contributed to improvement in predictive performance. Our code is available at https://github.com/Blue1993/BAPA.Author summaryThe initial step in drug discovery is to identify drug candidates for a target protein using a scoring function. Existing scoring functions, however, lack the ability to accurately predict the binding affinity of protein-ligand complexes. In this study, we proposed a deep learning-based approach to extract patterns from the local structures of protein-ligand complexes and to highlight the important local structures via an attention mechanism. The proposed model showed good performance for various benchmark datasets compared to existing models.

Improving the Accuracy of Protein-Ligand Binding Affinity Prediction by Deep Learning Models: Benchmark and Model

2019 ◽  
Author(s):  
Mohammad Rezaei ◽  
Yanjun Li ◽  
Xiaolin Li ◽  
Chenglong Li
Keyword(s):  
Deep Learning ◽  
Drug Design ◽  
Binding Affinity ◽  
Benchmark Dataset ◽  
Rational Drug Design ◽  
Learning Models ◽  
Structure Based Drug Design ◽  
Binding Affinity Prediction ◽  
Affinity Prediction ◽  
Rational Drug

<b>Introduction:</b> The ability to discriminate among ligands binding to the same protein target in terms of their relative binding affinity lies at the heart of structure-based drug design. Any improvement in the accuracy and reliability of binding affinity prediction methods decreases the discrepancy between experimental and computational results.<br><b>Objectives:</b> The primary objectives were to find the most relevant features affecting binding affinity prediction, least use of manual feature engineering, and improving the reliability of binding affinity prediction using efficient deep learning models by tuning the model hyperparameters.<br><b>Methods:</b> The binding site of target proteins was represented as a grid box around their bound ligand. Both binary and distance-dependent occupancies were examined for how an atom affects its neighbor voxels in this grid. A combination of different features including ANOLEA, ligand elements, and Arpeggio atom types were used to represent the input. An efficient convolutional neural network (CNN) architecture, DeepAtom, was developed, trained and tested on the PDBbind v2016 dataset. Additionally an extended benchmark dataset was compiled to train and evaluate the models.<br><b>Results: </b>The best DeepAtom model showed an improved accuracy in the binding affinity prediction on PDBbind core subset (Pearson’s R=0.83) and is better than the recent state-of-the-art models in this field. In addition when the DeepAtom model was trained on our proposed benchmark dataset, it yields higher correlation compared to the baseline which confirms the value of our model.<br><b>Conclusions:</b> The promising results for the predicted binding affinities is expected to pave the way for embedding deep learning models in virtual screening and rational drug design fields.

scholarly journals DeepPLA: a novel deep learning-based model for protein-ligand binding affinity prediction

2021 ◽  
Author(s):  
Bomin Wei ◽  
Xiang Gong
Keyword(s):  
Deep Learning ◽  
Ligand Binding ◽  
Binding Affinity ◽  
Binding Affinity Prediction ◽  
Affinity Prediction ◽  
New Drug ◽  
Drug Molecules ◽  
Approved Drugs ◽  
Vector Representations ◽  
Tremendous Challenge

AbstractThe substantial cost of new drug research and development has consistently posed a huge burden and tremendous challenge for both pharmaceutical companies and patients. In order to lower the expenditure and development failure rate, repurposing existing and approved drugs and identifying novel interactions between the drug molecules and the target proteins based on computational methods have gained growing attention. Here, we propose the DeepPLA, a novel deep learning-based model that combines ResNet-based 1D CNN and biLSTM, to establish an end-to-end network for protein-ligand binding affinity prediction. We first apply pre-trained embedding methods to encode the raw drug molecular SMILES strings and target protein sequences into dense vector representations. The dense vector representations separately go through ResNet-based 1D CNN modules to derive features. The extracted feature vectors are concatenated and further fed into the biLSTM network after average pooling operation, followed by the MLP module to finally predict binding affinity. We used BindingDB dataset for training and evaluating our DeepPLA model. The result shows that the DeepPLA model reaches a good performance for the protein-ligand binding affinity prediction in terms of R, RMSE, MAE, R2 and MSE with 0.89, 0.68, 0.50, 0.79 and 0.46 on the training set; and scores 0.84, 0.80, 0.60, 0.71 and 0.64 on the independent testing set, respectively. This result suggests the high accuracy of the DeepPLA prediction performance, as well as its high capability in generalization, demonstrating that the DeepPLA can be the potential upgrade to pinpoint new drug-target interactions to find better destinations for proven drugs.

MDeePred: novel multi-channel protein featurization for deep learning-based binding affinity prediction in drug discovery

2020 ◽  
Author(s):  
A S Rifaioglu ◽  
R Cetin Atalay ◽  
D Cansen Kahraman ◽  
T Doğan ◽  
M Martin ◽  
...  
Keyword(s):  
Neural Networks ◽  
Deep Learning ◽  
Drug Discovery ◽  
Binding Affinity ◽  
Deep Neural Networks ◽  
State Of The Art ◽  
Target Protein ◽  
Binding Affinity Prediction ◽  
Affinity Prediction ◽  
Compound Target

Abstract Motivation Identification of interactions between bioactive small molecules and target proteins is crucial for novel drug discovery, drug repurposing and uncovering off-target effects. Due to the tremendous size of the chemical space, experimental bioactivity screening efforts require the aid of computational approaches. Although deep learning models have been successful in predicting bioactive compounds, effective and comprehensive featurization of proteins, to be given as input to deep neural networks, remains a challenge. Results Here, we present a novel protein featurization approach to be used in deep learning-based compound–target protein binding affinity prediction. In the proposed method, multiple types of protein features such as sequence, structural, evolutionary and physicochemical properties are incorporated within multiple 2D vectors, which is then fed to state-of-the-art pairwise input hybrid deep neural networks to predict the real-valued compound–target protein interactions. The method adopts the proteochemometric approach, where both the compound and target protein features are used at the input level to model their interaction. The whole system is called MDeePred and it is a new method to be used for the purposes of computational drug discovery and repositioning. We evaluated MDeePred on well-known benchmark datasets and compared its performance with the state-of-the-art methods. We also performed in vitro comparative analysis of MDeePred predictions with selected kinase inhibitors’ action on cancer cells. MDeePred is a scalable method with sufficiently high predictive performance. The featurization approach proposed here can also be utilized for other protein-related predictive tasks. Availability and implementation The source code, datasets, additional information and user instructions of MDeePred are available at https://github.com/cansyl/MDeePred. Supplementary information Supplementary data are available at Bioinformatics online.

Sign in / Sign up

Export Citation Format

Share Document